A new initiative from the American Heart Association (AHA) aims to educate and engage pharmacists in caring for patients with AFib.

Does biosimilar competition lower costs for patients? Some Medicare health plans to start paying for weight-loss drugs. Hormonal contraception will be available without a prescription in New York pharmacies. Study links heart failure risk to e-cigarette use. Model sets out to tackle CVD disparities through pharmacy team partnerships. Semaglutide yields positive results for patients with obesity-related heart failure and T2D. 

FDA warns patients not to use smartwatches or smart rings to measure blood glucose levels. Survey looks at characteristics of young adults who use e-cigarettes. CDC: Older adults should get another COVID-19 dose this spring. BP improves with patients taking GLP-1, says study. Low-dose aspirin during pregnancy appears to have no effect on child’s neurodevelopment. Age-related risk of serious falls increases with opioid use. Pennsylvania pharmacists can now bill Medicaid for pharmacy services. 

CDC’s adult immunization schedule for 2024, which was published in the Annals of Internal Medicine on January 12, 2024, includes updates for several vaccines, such as those for respiratory syncytial virus (RSV), meningitis, mpox, and COVID-19.

Effective immediately, FDA has changed the labels on two medications used to bring down LDL cholesterol levels: bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet).